A. Čihák

2.0k total citations
125 papers, 1.6k citations indexed

About

A. Čihák is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, A. Čihák has authored 125 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 26 papers in Organic Chemistry and 21 papers in Infectious Diseases. Recurrent topics in A. Čihák's work include Biochemical and Molecular Research (41 papers), HIV/AIDS drug development and treatment (21 papers) and Cancer therapeutics and mechanisms (16 papers). A. Čihák is often cited by papers focused on Biochemical and Molecular Research (41 papers), HIV/AIDS drug development and treatment (21 papers) and Cancer therapeutics and mechanisms (16 papers). A. Čihák collaborates with scholars based in Czechia, United States and Japan. A. Čihák's co-authors include Jiří Veselý, F. Šorm, Henry C. Pitot, A. Pískala, David S. Wilkinson, J. Škoda, Hideo Inoue, Carlos Lamar, B Rada and Antonı́n Holý and has published in prestigious journals such as Journal of Biological Chemistry, Gut and Biochemical Journal.

In The Last Decade

A. Čihák

121 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. Čihák 1.1k 265 217 185 142 125 1.6k
Gary B. Henderson 841 0.7× 119 0.4× 91 0.4× 418 2.3× 175 1.2× 67 1.8k
John P. Durham 876 0.8× 136 0.5× 58 0.3× 130 0.7× 76 0.5× 41 1.1k
Gerald Wolberg 589 0.5× 114 0.4× 100 0.5× 130 0.7× 38 0.3× 39 1.0k
James E. Weiel 999 0.9× 226 0.9× 55 0.3× 148 0.8× 50 0.4× 28 1.8k
Richard B. Gilbertsen 770 0.7× 100 0.4× 260 1.2× 88 0.5× 101 0.7× 42 1.6k
Gregory Tombline 956 0.8× 155 0.6× 51 0.2× 619 3.3× 113 0.8× 41 1.6k
William C. Werkheiser 779 0.7× 45 0.2× 146 0.7× 167 0.9× 68 0.5× 24 1.2k
Jason D. Katz 946 0.8× 292 1.1× 335 1.5× 213 1.2× 49 0.3× 23 1.9k
Elizabeth Lovelace 616 0.5× 127 0.5× 46 0.2× 594 3.2× 24 0.2× 18 1.2k
Masashi Morita 1.6k 1.4× 95 0.4× 50 0.2× 389 2.1× 35 0.2× 89 2.1k

Countries citing papers authored by A. Čihák

Since Specialization
Citations

This map shows the geographic impact of A. Čihák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Čihák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Čihák more than expected).

Fields of papers citing papers by A. Čihák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Čihák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Čihák. The network helps show where A. Čihák may publish in the future.

Co-authorship network of co-authors of A. Čihák

This figure shows the co-authorship network connecting the top 25 collaborators of A. Čihák. A scholar is included among the top collaborators of A. Čihák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Čihák. A. Čihák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Čihák, A., et al.. (1987). Modulation of cell-mediated immunity with 5-azapyrimidine nucleosides.. PubMed. 10(2). 99–108. 1 indexed citations
2.
Čihák, A., et al.. (1977). [Participation of toxoplasmosis in the etiology of chronic tonsillitis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 68(1). 112–5. 1 indexed citations
3.
Kohout, Jiřı́, et al.. (1977). Inhibitory effect of various cytostatics and cycloheximide on acute experimental pancreatitis in rats.. Gut. 18(11). 913–918. 6 indexed citations
4.
Čihák, A. & B Rada. (1976). Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(3). 233–57. 24 indexed citations
5.
Čihák, A., et al.. (1976). Enhanced incorporation of thymidine into DNA in the liver of intact and partially hepatectomized rats pretreated with 5-azacytidine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(1). 37–42. 6 indexed citations
6.
Čihák, A., et al.. (1976). Enhanced mortality in offsprings of male mice treated with 5-azacytidine prior to mating. Morphological changes in testes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(1). 53–60. 7 indexed citations
7.
Čihák, A.. (1976). Stability of the Insoluble Form of Uridine Kinase Coupled to Zn2⊕or Pb2⊕Ions. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 357(1). 345–350. 2 indexed citations
8.
Čihák, A., et al.. (1976). Comparative study of mammalian uridine kinases in the soluble and Zn-precipitated form. International Journal of Biochemistry. 7(5). 187–192. 2 indexed citations
9.
Čihák, A., et al.. (1975). [Mechanism of cystostatic effect of 5-azacytidine and its usefulness in clinic].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 114(20). 607–11. 1 indexed citations
10.
Čihák, A.. (1975). Enhancement of uridine kinase activity in Escherichia coli B cultivated in the presence of metabolic inhibitors. Collection of Czechoslovak Chemical Communications. 40(3). 913–919.
11.
Čihák, A., et al.. (1974). Modulatory effect of cytostatics and chemical carcinogens on liver regeneration (a review).. PubMed. 21(5). 498–518. 11 indexed citations
12.
Čihák, A.. (1974). Inhibition of bacterial uracil phosphoribosyltransferase by uridine and 6-azauridine 5'-monophosphates. Collection of Czechoslovak Chemical Communications. 39(2). 673–679. 7 indexed citations
13.
Veselý, Jiří & A. Čihák. (1973). Uridine kinase in embryonic rat liver. Modulation of enzyme activity by 5-azacytidine. Biochemical Journal. 133(4). 609–613. 8 indexed citations
14.
Čihák, A., Carlos Lamar, & Henry C. Pitot. (1973). Studies on the mechanism of the stimulation of tyrosine aminotransferase activity in vivo by pyrimidine analogs: The role of enzyme synthesis and degradation. Archives of Biochemistry and Biophysics. 156(1). 176–187. 18 indexed citations
15.
Čihák, A., et al.. (1972). Dual effect of 5-azacytidine on the synthesis of liver ribonucleic acids. Biochemical Pharmacology. 21(18). 2497–2507. 20 indexed citations
16.
Čihák, A. & F. Šorm. (1972). Metabolic transformations of 5-azauracil and 5-azaorotic acid in mouse liver and escherichia coli. Biochemical Pharmacology. 21(5). 607–617. 12 indexed citations
17.
Čihák, A. & Henry C. Pitot. (1970). Incorporation of label from 5‐fluoroorotate into non‐ribosomal cytoplasmic RNA in rat liver. FEBS Letters. 6(3). 206–208. 13 indexed citations
18.
Veselý, Jiří & A. Čihák. (1970). Effect of L-tryptophan on DNA-dependent RNA polymerase in rat liver nuclei. Collection of Czechoslovak Chemical Communications. 35(6). 1892–1903. 2 indexed citations
19.
Čihák, A., V. Pliška, & F. Šorm. (1966). Inhibition of rat liver cystathionine synthetase by 3,5-dimethylthio-1,2,4-triazine. Collection of Czechoslovak Chemical Communications. 31(10). 4154–4163. 1 indexed citations
20.
Čihák, A., J. Škoda, & F. Šorm. (1963). Inhibition of biosynthesis of the nucleic acid pyrimidine bases by N-formylbiuret, a degradation product of 5-azauracil. Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects. 72. 125–127. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary B. Henderson Breakdown of academic impact, for papers by John P. Durham Breakdown of academic impact, for papers by Gerald Wolberg Breakdown of academic impact, for papers by James E. Weiel Breakdown of academic impact, for papers by Richard B. Gilbertsen Breakdown of academic impact, for papers by Gregory Tombline Breakdown of academic impact, for papers by William C. Werkheiser Breakdown of academic impact, for papers by Jason D. Katz Breakdown of academic impact, for papers by Elizabeth Lovelace Breakdown of academic impact, for papers by Masashi Morita
Rankless by CCL
2026